Post-Ablation Tissue Response Prediction Software
QZL is the FDA product code for Post-Ablation Tissue Response Prediction Software, a class II device type, regulated under 21 CFR 892.2052. FDA's definition for this code reads: "A Post-ablation tissue response prediction software is an image processing device intended to aid physicians with adjunctive information in their clinical assessment of the ablation zone following a tissue ablation procedure. This device uses information extracted from medical images along with other clinical data to...". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QZL
- Device name
- Post-Ablation Tissue Response Prediction Software
- FDA definition
- A Post-ablation tissue response prediction software is an image processing device intended to aid physicians with adjunctive information in their clinical assessment of the ablation zone following a tissue ablation procedure. This device uses information extracted from medical images along with other clinical data to predict the ablation zone post treatment.
- Regulation
- 21 CFR 892.2052
- Device class
- Class II
- Review panel
- Radiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code QZL
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
Applicants with the most clearances
Product code QZL| Applicant | Clearances |
|---|---|
| Techsomed Medical Technologies, Ltd. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
